The Prognostic Value of Androgen Receptor Splice Variant 7 in Castration-Resistant Prostate Cancer Treated With Novel Hormonal Therapy or Chemotherapy: A Systematic Review and Meta-analysis

PURPOSE: This study aimed to evaluate the prognostic role of AR-V7 in terms of prostate-specific antigen (PSA) response, progression-free survival (PFS), and overall survival (OS) in CRPC patients treated with novel hormonal therapy (NHT) (Abiraterone and Enzalutamide) or taxane-based chemotherapy (...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhize, Shen, Haixiang, Ma, Nieying, Li, Qinchen, Mao, Yeqing, Wang, Chaojun, Xie, Liping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793884/
https://www.ncbi.nlm.nih.gov/pubmed/33425724
http://dx.doi.org/10.3389/fonc.2020.572590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793884/
https://www.ncbi.nlm.nih.gov/pubmed/33425724
http://dx.doi.org/10.3389/fonc.2020.572590

Ejemplares similares